0000899243-20-033893.txt : 20201215 0000899243-20-033893.hdr.sgml : 20201215 20201215161014 ACCESSION NUMBER: 0000899243-20-033893 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201211 FILED AS OF DATE: 20201215 DATE AS OF CHANGE: 20201215 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Abel Robert Lorne CENTRAL INDEX KEY: 0001798179 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39206 FILM NUMBER: 201389701 MAIL ADDRESS: STREET 1: SCHRODINGER, INC. STREET 2: 120 WEST 45TH STREET, 17TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10036 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Schrodinger, Inc. CENTRAL INDEX KEY: 0001490978 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 954284541 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 120 WEST 45TH STREET STREET 2: 17TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10036 BUSINESS PHONE: 503-299-1150 MAIL ADDRESS: STREET 1: 120 WEST 45TH STREET STREET 2: 17TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10036 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-12-11 0 0001490978 Schrodinger, Inc. SDGR 0001798179 Abel Robert Lorne C/O SCHRODINGER, INC., 120 WEST 45TH STREET, 17TH FLOOR NEW YORK NY 0 1 0 0 EVP, Science Common Stock 2020-12-11 4 M 0 14224 3.07 A 40979 D Common Stock 2020-12-11 4 M 0 1649 2.92 A 42628 D Common Stock 2020-12-11 4 S 0 200 67.295 D 42428 D Common Stock 2020-12-11 4 S 0 5200 68.605 D 37228 D Common Stock 2020-12-11 4 S 0 4300 70.0091 D 32928 D Common Stock 2020-12-11 4 S 0 1885 70.654 D 31043 D Common Stock 2020-12-11 4 S 0 4118 72.3105 D 26925 D Common Stock 2020-12-11 4 S 0 21143 73.3027 D 5782 D Common Stock 2020-12-11 4 S 0 5782 74.006 D 0 D Stock Option (right to buy) 3.07 2020-12-11 4 M 0 14224 0.00 D 2026-05-10 Common Stock 14224 0 D Stock Option (right to buy) 2.92 2020-12-11 4 M 0 1649 0.00 D 2027-06-01 Common Stock 1649 7206 D These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 17, 2020. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $67.15 to $67.44, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) through (8) of this Form 4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $68.21 to $69.19, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $69.35 to $70.30, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $70.45 to $71.20, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $71.64 to $72.59, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $72.83 to $73.79, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $73.96 to $74.05, inclusive. The option was granted on May 11, 2016 and is fully vested. The option was granted on June 1, 2017. The shares underlying the option are scheduled to vest in equal yearly installments from January 1, 2017 through January 1, 2021. /s/ Donald Shum, as attorney-in-fact for Robert Lorne Abel 2020-12-15